RxDoctor Payments Data

John Garrison, DO

Internal Medicine · Henderson, NVNPI 1902284870

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Coloplast at 25.6% of the total. Among internal medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,033in general payments, 2019–2025

Across 238 payments — averaging $58.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$4K
  • Kerecis Limited$1K
  • AbbVie$1K
  • Organogenesis Inc.$1K
  • Bard Peripheral Vascular, Inc.$1K
  • Smith+Nephew$1K
  • plus $5K from 27 others

What the payments were for

  • Travel & lodging$5,68841%
  • Food & beverage$7,98757%
  • Education$3593%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,033 in reported general payments places this provider in the 95th percentile of 1,071 internal medicine providers in Nevada.

See all internal medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$404,604
Medicare patients
565
Services billed
3,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl16$640
Tamsulosin Hcl11$237
Pantoprazole Sodium13$205
Levothyroxine Sodium21$144
Atorvastatin Calcium25$128

Paid to pharmacies, not to this prescriber.

Other internal medicine in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →